Navigation Links
Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies
Date:8/18/2008

p>Each year, Frost & Sullivan presents this award to the company that has introduced truly innovative products, practices, or ideas to the specified industry or segment. The company's innovative contribution(s) to healthcare make it possible to envision a new level of care in the diagnosis, treatment, and management of disease, leading to better outcomes and quality-of-life for patients. In addition, the company's innovative efforts may also lead to improvements in the tools that clinicians, diagnosticians, researchers, and healthcare administrators have at their disposal to improve quality and efficiency in provision of healthcare services.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About ConforMIS

ConforMIS, Inc. is a privately held company that develops and commercializes medical devices for the treatment of osteoarthritis and joint damages. The Company's novel and scaleable 'image-to-implant' process is comprised of two related technology platforms. iFit(TM) Technology enables the creation of conforming, patient-specific implants that are precisely sized and shaped to match the 3D topography of the patient's anatomy. iJig(TM) Instrumentation enables the creation of disposable, easy-to-use instrumentation that simplifies the surgical process and improves reproducibility.

To date, ConforMIS has developed a comprehensive line of minimally traumatic, bone and cartilage-preserving knee implants and instrumentation designed to address all stages of osteoarthritis. Each of these devices has been cleared by the US Food a
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
2. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
3. Kingfisher Healthcare (KFH) Wins Prestigious Frost & Sullivan Best Practices Award
4. Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy
5. Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection
6. Therapy Could Save Limbs After Frostbite
7. Help Your Kids Earn an A for Attentiveness with a Bowl of Frosted Mini- Wheats(R) Cereal for Breakfast
8. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
9. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
10. MedApps Receives Prestigious Frost & Sullivan Award
11. Kelloggs Frosted Flakes Gold(TM) Helps Moms Get the Gold
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Oshkosh, Wisconsin (PRWEB) December 19, 2014 ... country music performer is again returning to the stage ... joining her husband for concert performances, and the successful ... show was originally announced. , Visit Ticketability.com ... for the newly-announced Detroit shows at fair prices. , ...
(Date:12/19/2014)... in good shape seems to reduce your risk of high ... more than 57,000 Americans, including more than 35,000 with high ... Those in the poorest shape had a more than ... start of the study, compared to a 50 percent chance ... more than 8,000 people diagnosed with high blood pressure during ...
(Date:12/19/2014)... Randy Dotinga HealthDay ... -- Common painkillers, including ibuprofen, might slightly reduce your ... say. Use of ibuprofen (Advil, Motrin) and naproxen ... skin cancer by 15 percent, the researchers concluded after ... usually caused by sun exposure. These ...
(Date:12/17/2014)... While countless companies tempt patients to buy hCG ... of their purchase. Not only is the sale of hCG ... patients who buy hCG online are typically receiving products that ... real hCG present. Illegal internet hCG is typically manufactured outside ... and may contain unknown fillers that can pose very serious ...
(Date:12/17/2014)... 17, 2014 HeartMath® Inc., recognized ... stress, heart rate variability (HRV), heart coherence and ... extensive HRV databases and algorithms to chipset manufacturers ... enable HeartMath’s partners to offer its HRV solutions, ... as well as its normative HRV databases and ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3
... 14 (HealthDay News) -- Military veterans who attempt suicide are ... have an overall heightened risk of death from all causes, ... in BioMed Central Public Health , looked at the ... Veterans Affairs medical center for a suicide attempt between 1993 ...
... THURSDAY, July 14 (HealthDay News) -- Before the advent of ... information -- such as phone numbers and birthdays -- than you ... the brain just doesn,t remember information as well if the person ... people may remember, however, is where they need to ...
... part of the Target Safely initiative, the American Society for ... of a series of such papers, on the safe use ... oncology clinic. The executive summary of this white paper is ... (PRO), ASTRO,s clinical practice journal. The full text of the ...
... 14 July 2011 Bristol-Myers Squibb today announced that ... treatment of adult patients with previously-treated advanced melanoma. ... the treatment of patients with advanced melanoma in a ... England Journal of Medicine in June 2010.(1) Based ...
... Whether patients with type 2 diabetes mellitus benefit from ... levels through treatment ("intensive blood glucose control") remains an ... a benefit but also of potential harm. This is ... Institute for Quality and Efficiency in Health Care (IQWiG). ...
... , WEDNESDAY, July 13 (HealthDay News) -- A new study ... patients thinking that real and fake drugs were doing the ... had a much greater physical effect on their lungs. ... were breathing much better even if they hadn,t taken a ...
Cached Medicine News:Health News: Can You Google Your Memory? 2Health News: Can You Google Your Memory? 3Health News: Can You Google Your Memory? 4Health News:ASTRO publishes white paper on IMRT safety 2Health News:YERVOY (ipilimumab) approved for the treatment of previously treated advanced melanoma in the EU 2Health News:YERVOY (ipilimumab) approved for the treatment of previously treated advanced melanoma in the EU 3Health News:Benefit of blood glucose lowering to near-normal levels remains unclear 2Health News:Benefit of blood glucose lowering to near-normal levels remains unclear 3Health News:Delving Into the Mystery of Placebos 2Health News:Delving Into the Mystery of Placebos 3
(Date:12/19/2014)... Since last month,s FBI shutdown of online ... the leading online black market for illegal drugs - ... offering of drugs and other illegal items.  New numbers ... succeed in lowering the numbers of drugs and illegal ... in August. But some new sites that have emerged ...
(Date:12/19/2014)... China separating membrane market has witnessed robust development ... years, albeit as a later starter. In 2012, the size ... approximated RMB12 billion, with the proportion worldwide soaring to 16.3%. ... membrane market will continue its growth rate by around 20% ... will jump to roughly RMB25 billion. An integrated ...
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
Breaking Medicine Technology:Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS Asserts its Position in Difficult Environment 2
... 21 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... of its,collaboration with the National Institute of ... institute supporting biodefense,research, under which the NIAID ... late-stage antibiotic, as a treatment for,anthrax and ...
... By ... Year- End 2007, ... focused on discovering and,developing novel RNA interference-based therapeutics, announced today that,it ... at,Buffalo, Center for Hearing & Deafness, which is the Company,s primary ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 2Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 3Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 4
The Clinac C family of accelerators are reliable, easy-to-use, flexible and cost-effective systems....
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y...
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Take Performance to a Higher Level....
Medicine Products: